title: [Axonal growth inhibition by chondroitin sulfate proteoglycans in the central nervous system].
abstract: Chondroitin sulphate proteoglycans (CSPG) are components of the extracellular matrix, consisting of peptides chemically attached covalently to chains of glycosaminoglycans. There are 4 families of CSPG including lecticans, which are found mainly in the central nervous system (CNS) of vertebrates. In vitro studies have shown a negative effect of these proteoglycans on axonal growth, mediated by depolymerization of actin filaments in the neuronal cytoskeleton. In some neurodegenerative diseases, and especially after traumatic injuries of adult CNS, there are increased levels of CSPG expression. Axonal growth inhibition by CSPG has been observed also in vivo, and therefore a strategy aimed to counteract the inhibition of axonal growth might lead to new therapies designed to restore neural circuits. There is compelling in vivo evidence that CSPG degradation by Chondroitinase ABC allows both axonal growth and functional recovery in models of injury in the mammalian CNS. These data suggest that manipulation of the response to damage could result in effective ways to promote recovery of nerve functions in neurological disorders that affect humans, such as spinal cord lesions or Parkinson disease.
authors.affiliation: Departamento de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México.
authors.forename: Néstor Emmanuel
authors.initials: NE
authors.lastname: Díaz-Martínez
authors.forename: Iván
authors.initials: I
authors.lastname: Velasco
mesh_terms: D000328:Adult; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D017690:Cell Transplantation; D002478:Cells, Cultured / Q000187:drug effects; D002490:Central Nervous System / Q000166:cytology* / Q000378:metabolism; D002648:Child; D019765:Chondroitin ABC Lyase / Q000502:physiology / Q000627:therapeutic use; D011508:Chondroitin Sulfate Proteoglycans / Q000737:chemistry / Q000145:classification / Q000494:pharmacology / Q000502:physiology*; D004353:Drug Evaluation, Preclinical; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005727:Ganglia, Spinal / Q000166:cytology; D005911:Gliosis / Q000378:metabolism; D006131:Growth Inhibitors / Q000502:physiology*; D006801:Humans; D015394:Molecular Structure; D009416:Nerve Regeneration / Q000187:drug effects / Q000502:physiology; D051381:Rats
chemical_list: D011508:Chondroitin Sulfate Proteoglycans; D016326:Extracellular Matrix Proteins; D006131:Growth Inhibitors; D019765:Chondroitin ABC Lyase